Contribution of the -160C/A Polymorphism in the E-cadherin Promoter to Cancer Risk: A Meta-Analysis of 47 Case-Control Studies

• Lin Wang ,

  Contributed equally to this work with: Lin Wang, Guiying Wang

  Affiliation Endocrinology Department, Shanghai East Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Science and Technology, Tongji University, Shanghai, People’s Republic of China

  ⨯
• Guiying Wang ,

  Contributed equally to this work with: Lin Wang, Guiying Wang

  Affiliation Endocrinology Department, Shanghai East Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Science and Technology, Tongji University, Shanghai, People’s Republic of China

  ⨯
• Chenqi Lu,

  Affiliation Laboratory of Population and Quantitative Genetics, Institute of Biostatistics, SKLGE, School of Life Sciences, Fudan University, Shanghai, People’s Republic of China

  ⨯
• Bo Feng ,

  * E-mail: fengbo@medmail.com (BF); jhkang@tongji.edu.cn (JK)

  Affiliation Endocrinology Department, Shanghai East Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Science and Technology, Tongji University, Shanghai, People’s Republic of China

  ⨯
• Jiuhong Kang

  * E-mail: fengbo@medmail.com (BF); jhkang@tongji.edu.cn (JK)

  Affiliation Endocrinology Department, Shanghai East Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Science and Technology, Tongji University, Shanghai, People’s Republic of China

  ⨯